223 related articles for article (PubMed ID: 9314093)
1. Treatment of left ventricular hypertrophy in hypertensive patients with a combination of verapamil and captopril--a multicenter study.
Magometschnigg D; Brandt D; Hofmann R; Sihorsch K; Stoschitzky K; Zangeneh M; Zenker G
Int J Clin Pharmacol Ther; 1997 Sep; 35(9):389-96. PubMed ID: 9314093
[TBL] [Abstract][Full Text] [Related]
2. Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function--a pilot study.
Gosse P; Gressin V; Clerson P; Lemetayer P; Clémenty J
Therapie; 1999; 54(2):217-22. PubMed ID: 10394257
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
Díez J; Laviades C
J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
[TBL] [Abstract][Full Text] [Related]
5. Effect of changes in blood pressure and left ventricular mass induced by antihypertensive treatment on ventricular arrhythmias in essential hypertension.
Muiesan ML; Zulli R; Rizzoni D; Calebich S; Malerba M; Porteri E; Agabiti-Rosei E
J Hypertens Suppl; 1993 Dec; 11(5):S104-5. PubMed ID: 8158296
[No Abstract] [Full Text] [Related]
6. [Evaluation of regression of left ventricular hypertrophy after antihypertensive therapy. Comparative echo-Doppler study of ace inhibitors and calcium antagonists].
Totteri A; Scopelliti G; Campanella G; Bertini M; Castro R; Pintus G; Jommi E
Minerva Cardioangiol; 1993 Jun; 41(6):231-7. PubMed ID: 8361609
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
[TBL] [Abstract][Full Text] [Related]
8. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
[TBL] [Abstract][Full Text] [Related]
9. Improvement of diastolic function after regression of left ventricular hypertrophy.
Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
[TBL] [Abstract][Full Text] [Related]
10. Absence of detectable regression of human hypertensive left ventricular hypertrophy following drug treatment for 1 year.
Laufer E; Reid C; Qi XL; Jennings GL
Clin Exp Pharmacol Physiol; 1998; 25(3-4):208-15. PubMed ID: 9590570
[TBL] [Abstract][Full Text] [Related]
11. Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats.
Ziegelhöffer-Mihalovicova B; Arnold N; Marx G; Tannapfel A; Zimmer HG; Rassler B
Life Sci; 2006 Jul; 79(9):838-46. PubMed ID: 16624325
[TBL] [Abstract][Full Text] [Related]
12. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
Gosse P; Roudaut R; Herrero G; Dallocchio M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients.
Scognamiglio R; Nosadini R; Marin M; Nisti S; Fasoli G; Palisi M; Frigato F; Virgili F; Carraro A; Crepaldi G
Diabetes Care; 1997 Aug; 20(8):1290-2. PubMed ID: 9250456
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effects of verapamil, captopril and their combination at rest and during dynamic exercise.
Di Somma S; Petitto M; Liguori V; Carotenuto A; Paulucci A; De Divitiis O
Arzneimittelforschung; 1992 Feb; 42(2):103-7. PubMed ID: 1610414
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
[TBL] [Abstract][Full Text] [Related]
17. Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy.
Machnig T; Henneke KH; Engels G; Pongratz G; Schmalzl M; Gellert J; Bachmann K
Cardiology; 1994; 85(2):101-10. PubMed ID: 7954561
[TBL] [Abstract][Full Text] [Related]
18. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Gottdiener JS; Reda DJ; Massie BM; Materson BJ; Williams DW; Anderson RJ
Circulation; 1997 Apr; 95(8):2007-14. PubMed ID: 9133508
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacologic regression of cardiac and vascular structural changes in the hypertensive patient. A question that goes beyond the exclusive medical bias].
Antonio Francischetti E; Genelhu Fagundes V; Francischetti A
Arq Bras Cardiol; 1995 Dec; 65(6):555-63. PubMed ID: 8731314
[No Abstract] [Full Text] [Related]
20. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
